SI3097084T1 - Novi zaviralci kalikreina 7 - Google Patents

Novi zaviralci kalikreina 7

Info

Publication number
SI3097084T1
SI3097084T1 SI201531440T SI201531440T SI3097084T1 SI 3097084 T1 SI3097084 T1 SI 3097084T1 SI 201531440 T SI201531440 T SI 201531440T SI 201531440 T SI201531440 T SI 201531440T SI 3097084 T1 SI3097084 T1 SI 3097084T1
Authority
SI
Slovenia
Prior art keywords
inhibitors
kallikrein
new
new kallikrein
Prior art date
Application number
SI201531440T
Other languages
English (en)
Inventor
Marcel Linschoten
Original Assignee
Sixera Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sixera Pharma Ab filed Critical Sixera Pharma Ab
Publication of SI3097084T1 publication Critical patent/SI3097084T1/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/38Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
SI201531440T 2014-01-23 2015-01-22 Novi zaviralci kalikreina 7 SI3097084T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1430004 2014-01-23
PCT/SE2015/050060 WO2015112079A1 (en) 2014-01-23 2015-01-22 New kallikrein 7 inhibitors
EP15740983.0A EP3097084B1 (en) 2014-01-23 2015-01-22 New kallikrein 7 inhibitors

Publications (1)

Publication Number Publication Date
SI3097084T1 true SI3097084T1 (sl) 2021-01-29

Family

ID=53681745

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201531440T SI3097084T1 (sl) 2014-01-23 2015-01-22 Novi zaviralci kalikreina 7

Country Status (16)

Country Link
US (1) US9744148B2 (sl)
EP (1) EP3097084B1 (sl)
JP (2) JP6552010B2 (sl)
CN (1) CN106132940B (sl)
AU (1) AU2015209759B2 (sl)
CA (1) CA2934024C (sl)
CY (1) CY1123707T1 (sl)
DK (1) DK3097084T3 (sl)
ES (1) ES2834851T3 (sl)
HR (1) HRP20201915T1 (sl)
HU (1) HUE052990T2 (sl)
LT (1) LT3097084T (sl)
PT (1) PT3097084T (sl)
RS (1) RS61142B1 (sl)
SI (1) SI3097084T1 (sl)
WO (1) WO2015112079A1 (sl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3305781A1 (en) * 2016-10-07 2018-04-11 Deutsches Krebsforschungszentrum Chemical substances which inhibit the enzymatic activity of human kallikrein-related peptidase 6 (klk6)
GB201809378D0 (en) 2018-06-07 2018-07-25 Glaxosmithkline Ip Dev Ltd Novel compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2514355A1 (fr) * 1981-10-14 1983-04-15 Fabre Sa Pierre Derives de biphenyl alcoyl carboxylates, leur procede de preparation et leur utilisation comme medicaments
WO2003101941A2 (en) * 2002-05-31 2003-12-11 Genzyme Corporation Alpha acyloxyacetamides for kallikrein and urokinase inhibition
ATE459359T1 (de) 2003-06-06 2010-03-15 Arexis Ab Verwendung von kondensierten heterozyklischen verbindungen als scce-hemmern zur behandlung von hautzuständen
EP2094082A2 (en) * 2006-11-23 2009-09-02 Vib Vzw Activators of lateral root formation
US8309596B2 (en) * 2007-06-28 2012-11-13 Novartis Ag Kallikrein 7 modulators
ES2527298T3 (es) 2007-08-17 2015-01-22 Novartis Ag Uso de depsipéptidos cíclicos para inhibir calicreína 7
EP2183273B1 (en) 2007-08-17 2017-04-05 Novartis AG Cyclic depsipeptides
US8143269B2 (en) * 2008-10-03 2012-03-27 Calcimedica, Inc. Inhibitors of store operated calcium release
EP2545916A1 (en) 2011-07-15 2013-01-16 Universite Pierre Et Marie Curie - Paris 6 Use of coumarin derivatives for the preparation of drugs for treating skin diseases

Also Published As

Publication number Publication date
CN106132940B (zh) 2019-04-23
US9744148B2 (en) 2017-08-29
CA2934024C (en) 2022-08-23
JP2017505299A (ja) 2017-02-16
CY1123707T1 (el) 2022-03-24
EP3097084A4 (en) 2017-10-04
JP6552010B2 (ja) 2019-07-31
HUE052990T2 (hu) 2021-05-28
DK3097084T3 (da) 2020-12-21
LT3097084T (lt) 2020-12-28
EP3097084A1 (en) 2016-11-30
RS61142B1 (sr) 2020-12-31
HRP20201915T1 (hr) 2021-01-22
WO2015112079A1 (en) 2015-07-30
AU2015209759B2 (en) 2018-11-29
JP6932386B2 (ja) 2021-09-08
CA2934024A1 (en) 2015-07-30
AU2015209759A1 (en) 2016-07-07
EP3097084B1 (en) 2020-09-30
JP2019163296A (ja) 2019-09-26
ES2834851T3 (es) 2021-06-18
CN106132940A (zh) 2016-11-16
US20170000753A1 (en) 2017-01-05
PT3097084T (pt) 2020-12-09

Similar Documents

Publication Publication Date Title
IL287113A (en) smyd inhibitors
IL280785A (en) Human plasma kallikrein inhibitors
IL259560A (en) Inhibitors of the menin-mll interaction
IL257880B (en) Beta-lactamase inhibitors
IL250642B (en) glycosidase inhibitors
IL246362A0 (en) Novel glutaminase inhibitors
IL246785A0 (en) Benzimidazole-2-amines as midh1 inhibitors
HK1226398A1 (zh) 作為midh1抑制劑的苯並咪唑-2-胺
GB201421088D0 (en) New enzyme inhibitors
IL248895A0 (en) Phosphatidylinositol 3-kinase inhibitors
GB201416446D0 (en) New enzyme inhibitor compounds
CU20160125A7 (es) Inhibidores de diacilglicerol aciltransferasa 2
GB201421085D0 (en) New enzyme inhibitors
GB201403536D0 (en) Inhibitor compounds
IL265139B (en) Dopamine-b-hydroxylase inhibitors
GB201612860D0 (en) Inhibitors
GB201501004D0 (en) Inhibitors
DK3237407T3 (da) 3,5-diaminopyrazolkinasehæmmere
RS61142B1 (sr) Novi inhibitori kalikreina 7
GB201401005D0 (en) Inhibitor
GB201520949D0 (en) Inhibitors
GB201418154D0 (en) Inhibitors
GB201413310D0 (en) Taggstar 2
IL233408A0 (en) New Skin - Perineal
GB201412713D0 (en) Soundwall 2